| L2, the minor capsid protein of papillomavirus JW Wang, RBS Roden Virology 445 (1-2), 175-186, 2013 | 309 | 2013 |
| Virus-like particles for the prevention of human papillomavirus-associated malignancies JW Wang, RBS Roden Expert review of vaccines 12 (2), 129-141, 2013 | 203 | 2013 |
| A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer RK Anchoori, B Karanam, S Peng, JW Wang, R Jiang, T Tanno, ... Cancer Cell 24 (6), 791-805, 2013 | 166 | 2013 |
| Immunologic Control of Mus musculus Papillomavirus Type 1 JW Wang, R Jiang, S Peng, YN Chang, CF Hung, RBS Roden PLoS pathogens 11 (10), e1005243, 2015 | 52 | 2015 |
| Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types K Kwak, R Jiang, JW Wang, S Jagu, R Kirnbauer, RBS Roden PloS one 9 (5), e97232, 2014 | 43 | 2014 |
| Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies JW Wang, S Jagu, K Kwak, C Wang, S Peng, R Kirnbauer, RBS Roden Virology 449, 304-316, 2014 | 43 | 2014 |
| Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells S Peng, L Song, J Knoff, JW Wang, YN Chang, D Hannaman, TC Wu, ... Cell & bioscience 4, 1-12, 2014 | 37 | 2014 |
| Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. TCW Shiwen Peng, Jin Qiu, Andrew Yang, Benjamin Yang, Jessica Jeang, Joshua ... Cell & Bioscience, 2016 | 32 | 2016 |
| Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus JW Wang, WH Wu, TC Huang, M Wong, K Kwak, K Ozato, CF Hung, ... Journal of virology 92 (15), 10.1128/jvi. 00572-18, 2018 | 29 | 2018 |
| Immunoprevention of human papillomavirus–associated malignancies JW Wang, C Hung, WK Huh, CL Trimble, RBS Roden Cancer prevention research 8 (2), 95-104, 2015 | 28 | 2015 |
| Spontaneous and vaccine-induced clearance of Mus musculus papillomavirus 1 infection RT Jiang, JW Wang, S Peng, TC Huang, C Wang, F Cannella, YN Chang, ... Journal of virology 91 (15), 10.1128/jvi. 00699-17, 2017 | 27 | 2017 |
| Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer S Peng, JW Wang, B Karanam, C Wang, WK Huh, RD Alvarez, SI Pai, ... PloS one 10 (1), e116389, 2015 | 27 | 2015 |
| Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions JW Wang, S Jagu, C Wang, HC Kitchener, S Daayana, PL Stern, S Pang, ... PLoS One 9 (7), e101576, 2014 | 26 | 2014 |
| Sero-epidemiology of HPV16 L2 and generation of papillomavirus L2-specific human chimeric monoclonal antibodies JW Wang, S Jagu, WH Wu, RP Viscidi, A Macgregor-Das, JM Fogel, ... Clinical and Vaccine Immunology 22 (7), 806-816, 2015 | 22* | 2015 |
| Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes NDC Subhashini Jagu, Balusubramanyam Karanam, Joshua W. Wang, Hatem Zayed ... Vaccine 33 (42), 5553–5563, 2015 | 21 | 2015 |
| Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation K Kwak, R Jiang, S Jagu, JW Wang, C Wang, ND Christensen, ... PloS one 8 (3), e60507, 2013 | 21 | 2013 |
| Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies JW Wang, K Matsui, Y Pan, K Kwak, S Peng, T Kemp, L Pinto, RBS Roden Current Protocols in Microbiology, 2015 | 13 | 2015 |
| Production and characterization of a novel HPV anti-L2 monoclonal antibody panel SM Bywaters, SA Brendle, J Biryukov, JW Wang, J Walston, J Milici, ... Virology 524, 106-113, 2018 | 6 | 2018 |
| Virus-like particle vaccines for the prevention of human papillomavirus infection JW Wang, RBS Roden, ML Tornesello, FM Buonaguro Virus-like Particles in Vaccine Development; Future Medicine: London, UK, 22-34, 2014 | 1 | 2014 |
| Spontaneous and vaccine-induced clearance of Mus Musculus Papillomavirus1 (MusPV1) infection RT Jiang, JW Wang, S Peng, CF Hung, RBS Roden Cancer Research 76 (14_Supplement), 2364-2364, 2016 | | 2016 |
Richard RodenProfessor, Department of Pathology, Johns Hopkins UniversityΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα jhmi.edu
